Serum miR-221 serves as a biomarker for Parkinson's disease.
about
Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease.MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease.Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patientsCirculating miRNAs as Diagnostic Biomarkers for Parkinson's DiseaseThe Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress
P2860
Serum miR-221 serves as a biomarker for Parkinson's disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Serum miR-221 serves as a biomarker for Parkinson's disease.
@en
Serum miR-221 serves as a biomarker for Parkinson's disease.
@nl
type
label
Serum miR-221 serves as a biomarker for Parkinson's disease.
@en
Serum miR-221 serves as a biomarker for Parkinson's disease.
@nl
prefLabel
Serum miR-221 serves as a biomarker for Parkinson's disease.
@en
Serum miR-221 serves as a biomarker for Parkinson's disease.
@nl
P2093
P2860
P356
P1476
Serum miR-221 serves as a biomarker for Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1002/CBF.3224
P577
2016-10-01T00:00:00Z